Table 4. Details of actual assays used


Initial tests Manufacturer of initial test Manufacturer of confirmatory tests*

Hepatitis B virus
B surface antigen (EIA) Bioelisa (Launch) (March 91-June 93) Organon Hepanostika (June 93-June 94) Murex (June 94-Dec 96) Pasteur, GEIS
Anti-B core (EIA) Wellcozyme Wellcozyme, Abbott IMx
Anti-B surface  --- Wellcozyme, Abbott IMx
Hepatitis C virus
Anti-C (EIA) Ortho II (Sept 91-May 93) Murex (May 93-June 93) Ortho III (June 93-Aug 93) Murex (Aug 93-Aug 95) Pasteur (Aug 95-Dec 96)  ---
Anti-C virus (EIA)  --- Ortho, Sanofi
Anti-C virus RIBA-3  --- Chiron
HIV
Anti-HIV 1+2 (EIA) Wellcozyme  ---
Anti-HIV  --- Immunometric, GPA, western blot
Human T cell leukaemia/lymphoma virus
Anti-HTLV (GPA) Fuji  ---
Anti-HTLV  --- Select antiglobulin

* Performed at reference laboratory (Department of Virology, Royal Free and University College Medical School).
EIA=enzyme linked immunoassay.
GPA=gel particle agglutination assay.